http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Bextra-P32/News/ What is Bextra? Prior to being removed from the market at the request of the FDA, Bextra was prescribed to deal with symptoms of osteoarthritis, rheumatoid arthritis and painful menstrual cycles. Bextra has the generic name of valdecoxib, and was marketed by Pfizer. Bextra is a member of the class of drugs known as non-steroidal anti-inflammatory drugs, also known as NSAIDs. Bextra and other NSAIDs are used in the treatment of pain and inflammation. Other well-known NSAIDs include aspirin and ibuprofen. Within this class of NSAIDS, Bextra is a cox-2 inhibitor, which is a classification Bextra shares ... en-us http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Bextra-P32/News/Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature. http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Bextra-P32/News/Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Bextra-P32/News/ Los Angeles, California (PRWEB) January 18, 2006 -– Lawsuits continue to be filed against Pfizer, the maker of Bextra, although Bextra was removed from U.S. and Canadian shelves months ago. Bex... http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Bextra-P32/News/ TORONTO (CP) - The painkiller Bextra will not be allowed back on the Canadian market, Health Canada announced Friday.